MedTrace Logo

Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

NCT00261937 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2013-02-06

No results posted yet for this study

Summary

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

Conditions

  • Bronchiolitis

Interventions

DRUG

Inhaled Furosemide vs Placebo (Normal Saline)

Sponsors & Collaborators

  • Bnai Zion Medical Center

    lead OTHER_GOV

Principal Investigators

  • Amir Kugelman · Bnai Zion Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Completion
2006-04-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00261937 on ClinicalTrials.gov